128 related articles for article (PubMed ID: 17888034)
1. Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancer.
Mano Y; Takahashi K; Ishikawa N; Takano A; Yasui W; Inai K; Nishimura H; Tsuchiya E; Nakamura Y; Daigo Y
Cancer Sci; 2007 Dec; 98(12):1902-13. PubMed ID: 17888034
[TBL] [Abstract][Full Text] [Related]
2. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression.
Hirata D; Yamabuki T; Miki D; Ito T; Tsuchiya E; Fujita M; Hosokawa M; Chayama K; Nakamura Y; Daigo Y
Clin Cancer Res; 2009 Jan; 15(1):256-66. PubMed ID: 19118053
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
5. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer.
Taniwaki M; Takano A; Ishikawa N; Yasui W; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6624-31. PubMed ID: 18006763
[TBL] [Abstract][Full Text] [Related]
6. Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer.
Takano A; Ishikawa N; Nishino R; Masuda K; Yasui W; Inai K; Nishimura H; Ito H; Nakayama H; Miyagi Y; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Cancer Res; 2009 Aug; 69(16):6694-703. PubMed ID: 19679554
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.
Sunaga N; Kaira K; Imai H; Shimizu K; Nakano T; Shames DS; Girard L; Soh J; Sato M; Iwasaki Y; Ishizuka T; Gazdar AF; Minna JD; Mori M
Oncogene; 2013 Aug; 32(34):4034-42. PubMed ID: 22964644
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
[TBL] [Abstract][Full Text] [Related]
9. Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer.
Masuda K; Takano A; Oshita H; Akiyama H; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Clin Cancer Res; 2011 Dec; 17(24):7712-22. PubMed ID: 22016508
[TBL] [Abstract][Full Text] [Related]
10. Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer.
Furukawa C; Daigo Y; Ishikawa N; Kato T; Ito T; Tsuchiya E; Sone S; Nakamura Y
Cancer Res; 2005 Aug; 65(16):7102-10. PubMed ID: 16103059
[TBL] [Abstract][Full Text] [Related]
11. Activation of an oncogenic TBC1D7 (TBC1 domain family, member 7) protein in pulmonary carcinogenesis.
Sato N; Koinuma J; Ito T; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
Genes Chromosomes Cancer; 2010 Apr; 49(4):353-67. PubMed ID: 20095038
[TBL] [Abstract][Full Text] [Related]
12. Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis.
Koinuma J; Akiyama H; Fujita M; Hosokawa M; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
Cancer Sci; 2012 Mar; 103(3):577-86. PubMed ID: 22129094
[TBL] [Abstract][Full Text] [Related]
13. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.
Suzuki C; Daigo Y; Ishikawa N; Kato T; Hayama S; Ito T; Tsuchiya E; Nakamura Y
Cancer Res; 2005 Dec; 65(24):11314-25. PubMed ID: 16357138
[TBL] [Abstract][Full Text] [Related]
14. Low expression of Mig-6 is associated with poor survival outcome in NSCLC and inhibits cell apoptosis via ERK-mediated upregulation of Bcl-2.
Li Z; Qu L; Zhong H; Xu K; Qiu X; Wang E
Oncol Rep; 2014 Apr; 31(4):1707-14. PubMed ID: 24573418
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of a novel FGFR1OP-RET rearrangement in hematopoietic malignancies.
Bossi D; Carlomagno F; Pallavicini I; Pruneri G; Trubia M; Raviele PR; Marinelli A; Anaganti S; Cox MC; Viale G; Santoro M; Di Fiore PP; Minucci S
Mol Oncol; 2014 Mar; 8(2):221-31. PubMed ID: 24315414
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of P21-Activated Kinase 1 (PAK1)/CREB Axis in Squamous Non-Small Cell Lung Carcinoma.
Chung JH; Kim DH; Kim YS; Son BS; Kim D; Hwang C; Shin D; Noh SG; Han JH; Kim DK; Kim JH; Koo JS; Chung HY; Yoon SH
Cell Physiol Biochem; 2018; 50(1):304-316. PubMed ID: 30282071
[TBL] [Abstract][Full Text] [Related]
17. High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.
Nunez MI; Behrens C; Woods DM; Lin H; Suraokar M; Kadara H; Hofstetter W; Kalhor N; Lee JJ; Franklin W; Stewart DJ; Wistuba II
J Thorac Oncol; 2012 May; 7(5):833-40. PubMed ID: 22729036
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non-small cell lung carcinoma.
Qiu Y; Morii E; Tomita Y; Zhang B; Matsumura A; Kitaichi M; Okumura M; Aozasa K
Cancer Sci; 2009 Jul; 100(7):1198-209. PubMed ID: 19356220
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of fibroblast growth factor 1 in non-small cell lung cancer.
Li J; Wei Z; Li H; Dang Q; Zhang Z; Wang L; Gao W; Zhang P; Yang D; Liu J; Sun Y; Gao W
Hum Pathol; 2015 Dec; 46(12):1821-8. PubMed ID: 26391572
[TBL] [Abstract][Full Text] [Related]
20. Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study.
Gridelli C; de Marinis F; Ardizzoni A; Novello S; Fontanini G; Cappuzzo F; Grossi F; Santo A; Cortinovis D; Favaretto A; Lorusso V; Galetta D; Siena S; Bettini A; Iurlaro M; Caprioli A;
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1783-93. PubMed ID: 24903964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
